(Q44786184)

6 December 2017

title

Powder-in-bottle formulation of SU011248. Enabling rapid progression into human clinical trials (English)

1 reference

6 December 2017

Anand Sistla

1

1 reference

6 December 2017

Alan Sunga

2

1 reference

6 December 2017

Kenneth Phung

3

1 reference

6 December 2017

Arun Koparkar

4

1 reference

6 December 2017

Narmada Shenoy

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

Drug Development and Industrial Pharmacy

6 December 2017

published in

1 reference

6 December 2017

volume

30

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

19-25

1 reference

In-use testing of extemporaneously prepared suspensions of second generation non-nucleoside reversed transcriptase inhibitors in support of phase I clinical studies

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120027507

Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120027507

Stability of extemporaneous norfloxacin suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120027507

Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120027507

21 January 2018

Identifiers

DOI

10.1081/DDC-120027507

1 reference

6 December 2017

1 reference